View Post

U.S. Distributes Monoclonal Antibodies This Week, But Not COVID-19 Pills

In COVID-19, Latest News by Precision Vaccinations

The U.S. HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced it was distributing 225,590​ monoclonal antibody treatments but no COVID-19 oral antivirals this week.
There are four mAbs Authorized but not Approved by the U.S. FDA to treat certain patients as of January 17, 2022.
The ASPR distribution list shows the total number of patient courses that have been distributed across the country.

View Post

Un-Common Gene Indicates COVID-19 Risk

In COVID-19, Latest News by Precision Vaccinations

Scientists in Poland may have discovered a gene that more than doubles the risk of severe COVID-19.
Researchers from the Medical University of Bialystok in Poland found that the gene is the fourth most important factor determining how a person suffers from COVID-19, after age, weight, and gender. 
This gene is located on chromosome 3, one of the 23 pairs of chromosomes in humans, and is present in around 14% of the Polish population, compared to 8-9% in Europe, and 27% in India.

View Post

Cross-Reactive T Cells Associated with SARS-CoV-2 Protection

In COVID-19, Latest News by Precision Vaccinations

A new study, published in Nature Communications on January 10, 2022, and led by Imperial College London researchers, provides evidence of a protective role for T cells.
This study suggests that the initial frequency of IL-2-secreting cross-reactive T cells is associated with protection from infection in COVID-19 contacts. 

View Post

Measles, Tuberculosis Vaccines Could ‘Flatten the COVID-19 Curve’

In COVID-19, Latest News by Precision Vaccinations

Researchers at Weill Cornell Medicine and the University of Oxford announced on January 10, 2022, their new study shows that common vaccines could help reduce the health burden of the COVID-19 pandemic. 
A peer-reviewed study published in the Proceedings of the National Academy of Sciences crystallizes decades of evidence suggesting that the generalized immune-boosting properties of many vaccines can cross-protect people against multiple pathogens.

View Post

COVID-19 Vaccination Slightly Impacts Menstrual Cycles

In COVID-19, Latest News by Precision Vaccinations

A peer-reviewed study published by the journal Obstetrics & Gynecology on January 5, 2022, found that women receiving one dose of a COVID-19 vaccine during a single menstrual cycle had an increase in cycle length of nearly one day.
And a study subgroup that received two COVID-19 vaccine doses in the same menstrual cycle (358 users) had a more significant average increase in cycle length of two days.
However, this change appears to decrease in subsequent cycles, indicating that the menstrual changes likely are temporary.

View Post

Influenza Vaccination Failed to Reduce COVID-19 Risk

In COVID-19, Latest News by Precision Vaccinations

In a new study from the University of Copenhagen, vaccination against influenza was found to not change the risk of hospitalization or symptoms due to COVID-19.
And influenza vaccination was not associated with the risk of contracting SARS-CoV-2 infection as assessed by the presence of antibodies against SARS-CoV-2. 
This study focused on the working population and subgroup analyses of outcomes related to the severity of disease included a sparse number of HCW aged ≥65 who had contracted SARS-CoV-2.

View Post

Identified Gene May Double Severe COVID-19 Risk

In COVID-19, Latest News by Precision Vaccinations

Oxford University issued a media statement saying, ‘Scientists have identified the gene responsible for doubling the risk of respiratory failure from COVID-19.’
Genome-wide association studies identified the 3p21.31 region of the human DNA as conferring a two-fold increased risk of respiratory failure.
And about 60% of people with South Asian ancestry carry the high-risk genetic signal, compared to 15% of those with European ancestry.

View Post

CDC Clarifies COVID-19 Antibody Testing Specificity

In COVID-19, Latest News by Precision Vaccinations

During the current COVID-19 pandemic, maximizing lab test specificity is significant, says the US Centers for Disease Control and Prevention (CDC) in its 'Interim Guidelines for COVID-19 Antibody Testing.'
On May 23, 2020, the CDC said 'positive predictive value in a serologic algorithm is preferred in most instances since the overall prevalence of SARS-CoV-2 antibodies is likely low in most states, except New York. 

View Post

Which COVID-19 Antibody Treatment is Available?

In COVID-19, Latest News by Precision Vaccinations

With increased consumer demand for COVID-19 antibody (mAbs) treatments, many states have recently run out of supply for their citizens.
Since the U.S. government is the primary source of these innovative and effective mAbs treatments, many healthcare providers are turning away prospective patients.